🕵️ Recursion Pharmaceuticals, Inc. ($RXRX)
SEC insider & ownership activity, last 12 months · CIK 1601830 · every row links its SEC filing
Over the last 12 months insiders sold $13.1M with no open-market buying against it. Gibson Christopher sold $8.1M through a program of 34 sale notices averaging $343K (Aug–Jun). 2 planned sales are pending, the largest $962K (Gibson Christopher). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 5 sellers, $13.1M (39 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Gibson Christopher | 0 | – | 22 | $8.1M | Jun 5, 2026 |
| Borgeson Blake | 0 | – | 8 | $3.9M | Jul 7, 2026 |
| Khan Najat | 0 | – | 4 | $930K | Jun 5, 2026 |
| Ben R. Taylor | 0 | – | 3 | $158K | Mar 17, 2026 |
| Bumpus Namandje | 0 | – | 2 | $28K | Jun 18, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| ARK Investment Management LLC | 8.5% | 13G | Feb 14, 2025 | filing ↗ | |
| ARK Investment Management LLC | 7.2% | 13G | Feb 3, 2026 | filing ↗ | |
| Catherine D. Wood | 7.2% | 13G | Feb 3, 2026 | filing ↗ | |
| Blackrock, Inc. | 7.2% | 13G | Apr 24, 2026 | filing ↗ | |
| State Street Corporation | 5.5% | 13G | May 12, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Gibson Christopher | $153K | Jul 27, 2026 | filing ↗ |
| Gibson Christopher | $304K | Jul 21, 2026 | filing ↗ |
| Gibson Christopher | $290K | Jul 20, 2026 | filing ↗ |
| Gibson Christopher | $297K | Jul 17, 2026 | filing ↗ |
| Gibson Christopher | $311K | Jul 16, 2026 | filing ↗ |
| Gibson Christopher | $410K | Jul 15, 2026 | filing ↗ |
| Gibson Christopher | $330K | Jul 14, 2026 | filing ↗ |
| Gibson Christopher | $343K | Jul 13, 2026 | filing ↗ |
| Gibson Christopher | $354K | Jul 10, 2026 | filing ↗ |
| Gibson Christopher | $1.1M | Jul 9, 2026 | filing ↗ |
| Gibson Christopher | $738K | Jul 8, 2026 | filing ↗ |
| Gibson Christopher | $988K | Jul 7, 2026 | filing ↗ |
| Borgeson Blake | $158K | Jul 7, 2026 | filing ↗ |
| Gibson Christopher | $378K | Jul 6, 2026 | filing ↗ |
| Gibson Christopher | $374K | Jul 2, 2026 | filing ↗ |
| Gibson Christopher | $367K | Jul 1, 2026 | filing ↗ |
| Gibson Christopher | $962K | Jun 18, 2026 | filing ↗ |
| Bumpus Namandje | $13K | Jun 18, 2026 | filing ↗ |
| Gibson Christopher | $127K | Jun 18, 2026 | filing ↗ |
| Gibson Christopher | $145K | Jun 5, 2026 | filing ↗ |
| Najat Khan | $84K | Jun 5, 2026 | filing ↗ |
| Bumpus Namandje | $16K | Jun 3, 2026 | filing ↗ |
| Borgeson Blake | $110K | Jun 2, 2026 | filing ↗ |
| Gibson Christopher | $123K | May 22, 2026 | filing ↗ |
| Gibson Christopher | $135K | May 7, 2026 | filing ↗ |
| Borgeson Blake | $106K | May 5, 2026 | filing ↗ |
| Gibson Christopher | $144K | Apr 22, 2026 | filing ↗ |
| Gibson Christopher | $124K | Apr 7, 2026 | filing ↗ |
| Borgeson Blake | $93K | Apr 7, 2026 | filing ↗ |
| Gibson Christopher | $130K | Mar 23, 2026 | filing ↗ |
| Ben R. Taylor | $27K | Mar 17, 2026 | filing ↗ |
| Najat Khan | $95K | Mar 9, 2026 | filing ↗ |
| Borgeson Blake | $588K | Mar 3, 2026 | filing ↗ |
| Gibson Christopher | $138K | Feb 19, 2026 | filing ↗ |
| Ben R. Taylor | $41K | Feb 18, 2026 | filing ↗ |
| Gibson Christopher | $165K | Feb 4, 2026 | filing ↗ |
| Borgeson Blake | $924K | Feb 3, 2026 | filing ↗ |
| Gibson Christopher | $179K | Jan 20, 2026 | filing ↗ |
| Borgeson Blake | $959K | Jan 6, 2026 | filing ↗ |
| Gibson Christopher | $170K | Jan 5, 2026 | filing ↗ |
| Ben R. Taylor | $89K | Dec 29, 2025 | filing ↗ |
| Najat Khan | $549K | Dec 22, 2025 | filing ↗ |
| Gibson Christopher | $180K | Dec 19, 2025 | filing ↗ |
| Gibson Christopher | $185K | Dec 4, 2025 | filing ↗ |
| Borgeson Blake | $961K | Dec 2, 2025 | filing ↗ |
| Gibson Christopher | $166K | Nov 19, 2025 | filing ↗ |
| Gibson Christopher | $208K | Nov 4, 2025 | filing ↗ |
| Gibson Christopher | $570K | Oct 23, 2025 | filing ↗ |
| Gibson Christopher | $604K | Oct 10, 2025 | filing ↗ |
| Gibson Christopher | $476K | Sep 25, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Shareholder vote (5.07) | Jun 17, 2026 | filing ↗ |
| Earnings (2.02) | May 6, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 6, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 28, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 28, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 25, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 25, 2026 | filing ↗ |
| Earnings (2.02) | Feb 25, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 25, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Other events (8.01) | Dec 8, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 8, 2025 | filing ↗ |
| Other events (8.01) | Nov 26, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 26, 2025 | filing ↗ |
| Earnings (2.02) | Nov 4, 2025 | filing ↗ |
| Officer/director changes (5.02) | Nov 4, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 4, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 4, 2025 | filing ↗ |
| Other events (8.01) | Oct 29, 2025 | filing ↗ |
| Earnings (2.02) | Aug 5, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 5, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Jul 8, 2025 | filing ↗ |
| Other events (8.01) | Jul 8, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 8, 2025 | filing ↗ |